Red Light Holland Corp

OTCQB:TRUFF USA Drug Manufacturers - Specialty & Generic
Market Cap
$8.87 Million
Market Cap Rank
#29951 Global
#9895 in USA
Share Price
$0.02
Change (1 day)
-8.70%
52-Week Range
$0.02 - $0.03
All Time High
$0.50
About

Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. It sells its pro… Read more

Red Light Holland Corp (TRUFF) - Net Assets

Latest net assets as of September 2025: $15.61 Million USD

Based on the latest financial reports, Red Light Holland Corp (TRUFF) has net assets worth $15.61 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.02 Million) and total liabilities ($3.41 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $15.61 Million
% of Total Assets 82.09%
Annual Growth Rate 54.02%
5-Year Change -49.05%
10-Year Change N/A
Growth Volatility 69.23

Red Light Holland Corp - Net Assets Trend (2019–2025)

This chart illustrates how Red Light Holland Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Red Light Holland Corp (2019–2025)

The table below shows the annual net assets of Red Light Holland Corp from 2019 to 2025.

Year Net Assets Change
2025-03-31 $17.35 Million -14.38%
2024-03-31 $20.26 Million -23.08%
2023-03-31 $26.34 Million -9.65%
2022-03-31 $29.16 Million -14.38%
2021-03-31 $34.06 Million +3076.07%
2020-03-31 $-1.14 Million -188.10%
2019-03-31 $1.30 Million --

Equity Component Analysis

This analysis shows how different components contribute to Red Light Holland Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3340477800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Other Components $59.55 Million 343.19%
Total Equity $17.35 Million 100.00%

Red Light Holland Corp Competitors by Market Cap

The table below lists competitors of Red Light Holland Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Red Light Holland Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 20,070,195 to 17,352,380, a change of -2,717,815 (-13.5%).
  • Net loss of 4,042,202 reduced equity.
  • Other factors increased equity by 1,324,387.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-4.04 Million -23.29%
Other Changes $1.32 Million +7.63%
Total Change $- -13.54%

Book Value vs Market Value Analysis

This analysis compares Red Light Holland Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.50x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-03-31 $-0.01 $0.02 x
2020-03-31 $-0.01 $0.02 x
2021-03-31 $0.16 $0.02 x
2022-03-31 $0.08 $0.02 x
2023-03-31 $0.07 $0.02 x
2024-03-31 $0.05 $0.02 x
2025-03-31 $0.04 $0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Red Light Holland Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -23.29%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -81.75%
  • • Asset Turnover: 0.23x
  • • Equity Multiplier: 1.22x
  • Recent ROE (-23.29%) is below the historical average (-19.61%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 0.00% -1660.28% 0.00x 0.00x $86.82K
2020 0.00% -293.06% 0.03x 0.00x $-210.74K
2021 -4.83% -1482.41% 0.00x 1.07x $-5.05 Million
2022 -50.45% -617.78% 0.07x 1.16x $-17.21 Million
2023 -20.71% -136.67% 0.13x 1.16x $-8.00 Million
2024 -38.00% -160.51% 0.20x 1.20x $-9.63 Million
2025 -23.29% -81.75% 0.23x 1.22x $-5.78 Million

Industry Comparison

This section compares Red Light Holland Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Red Light Holland Corp (TRUFF) $15.61 Million 0.00% 0.22x $7.16 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million